Breast, Prostate Cancer Common in Patients With COVID-19 and Cancer History
For patients hospitalized with COVID-19, prostate cancer was the most common cancer type across all databases.
For patients hospitalized with COVID-19, prostate cancer was the most common cancer type across all databases.
Survey responses revealed a lack of culturally competent care and tailored resources.
The intervention also improved the rate of advance directive completion.
The sensor detected fevers a median of 4.9 hours earlier than did standard care.
There was a significant increase in out-of-pocket costs for all 4 cancer types studied.
Cancer patients were less likely to receive critical care, whether they were on active anticancer treatment or not.
Most vaccinated patients reported having mild side effects or none at all.
Most patients with solid tumors demonstrate immune responses to COVID-19 vaccines, but a subset of patients do not.
Experts outline benefits and detriments of COVID-19 vaccine mandates.
The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic.